Effectiveness of Different Treatment Modalities in Postmenopausal Women with Osteopenia and Osteoporosis

Authors

  • Berfu Demir Department of Obstetrics and Gynecology, Etlik Zübeyde Hanım Maternity & Women’s Health Teaching and Research Hospital, Ankara
  • Enis Özkaya Department of Obstetrics and Gynecology, Etlik Zübeyde Hanım Maternity & Women’s Health Teaching and Research Hospital, Ankara
  • Nilgün Öztürk Department of Obstetrics and Gynecology, İzmit Acıbadem Hospital, İzmit
  • Burak Karadag Department of Obstetrics and Gynecology, Etlik Zübeyde Hanım Maternity & Women’s Health Teaching and Research Hospital, Ankara
  • Ali Haberal Department of Obstetrics and Gynecology, Etlik Zübeyde Hanım Maternity & Women’s Health Teaching and Research Hospital, Ankara

Keywords:

Menopause, Bone mineral density, Hormone therapy, Antiresorptive treatment

Abstract

OBJECTIVE: The aim of this study was to evaluate the efficacy of different antiresorptive agents and hormone therapy (HT) on T score and to compare their effectiveness with each other.
STUDY DESIGN: Medical records of 1073 postmenopausal women were reviewed. Patients were classified into four groups; hormone therapy, antiresorptive therapy (AT), combined HT and AT and control. Groups were evaluated with their response to treatment modality by measuring the changes on T score. Also, patients of HT and AT groups were compared with each other according to the effectiveness of the
treatment on T score changes.
RESULTS: Treatment related increase in T score was significantly different in HT-AT and AT groups compared with the HT group (P=0.001, P=0.001). Within the HT group (estrogen: 170, estrogen-progestin: 234, tibolone: 136) the alteration on T score was statistically significant compared to the control group (P=0.001, P=0.001, P = 0.001). Within the AT group (etidronate: 165, alendronate: 94, risedronate
: 11, calcitonin: 10) all agents were significantly different compared to the control group according to the alterations on T score (P=0.001, P=0.001, P=0.001, P = 0.001). When the change in T score was compared, the alendronate group was significantly different than the etidronate group (P=0.001).
CONCLUSION: Hormone therapy combined with AT and AT alone was found to be superior to HT in terms of increments in T score values in postmenopausal women with osteopenia and osteoporosis.

Downloads

Download data is not yet available.

Downloads

Published

2009-12-12

How to Cite

1.
Demir B, Özkaya E, Öztürk N, Karadag B, Haberal A. Effectiveness of Different Treatment Modalities in Postmenopausal Women with Osteopenia and Osteoporosis. Gynecol Obstet Reprod Med [Internet]. 2009Dec.12 [cited 2024Nov.22];15(3):153-6. Available from: https://gorm.com.tr/index.php/GORM/article/view/393

Issue

Vol. 15 No. 3 (2009)

Section

Reproductive Medicine: Endocrinology and Infertility

License

CC BY

All the articles published in GORM are licensed with "Creative Commons Attribution 4.0 License (CC BY 4.0)". This license entitles all parties to copy, share and redistribute all the articles, data sets, figures and supplementary files published in this journal in data mining, search engines, web sites, blogs and other digital platforms under the condition of providing references.